Pfizer estimates $54 billion in revenue for 2022 from its COVID-19 vaccine and antiviral pill alone, powering an expected record of $102 billion overall…
View original article on cntpd.link
Help Centipede Nation Stay Online
Stories like these are made possible by contributions from readers like you. If everyone who enjoys our website helps fund it, we can keep our platform alive and expand our coverage further.